SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 90 Minutes
There are many causes of hematological abnormalities, including chronic diseases, nutritional deficits, medication side effects, and many more. It is important for clinicians’ to understand the normal process of hematopoiesis to correctly diagnose and manage the many different types of hematological disorders that exist. During this webcast, expert faculty will discuss the diagnosis and management of several common hematologic disorders.
This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.
1. Describe the normal process of hematopoiesis and the differential diagnosis of cytopenias, including anemia, thrombocytopenia and leukopenia
2. Discuss common hematologic disorders that may result in elevated blood counts
3. Identify recommended diagnostic testing to establish a diagnosis of immune thrombocytopenia (ITP) and anemia
4. Recognize clinical management strategies for patients with bleeding disorders, including hemophilia and Von Willebrand Disease
Sandra Kurtin, PhD, ANP-C, AOCN
Sandra E. Kurtin, PhD, ANP-C, AOCN, graduated from the University of Arizona with a Bachelor of Science in Nursing with high distinction, followed by a Master of Science in Oncology Nursing, a post-graduate certification in both Geriatric and Adult Practice, and a PhD in Nursing. Her research focus is on heath technology engagement and communicative health literacy aimed at improving health self-management among older adult cancer survivors and their caregivers. Dr. Kurtin maintains a busy clinical practice at the University of Arizona Cancer Center and holds appointments as an Assistant Professor of Clinical Medicine and Adjunct Clinical Assistant Professor of Nursing at the University of Arizona. She is the Director of Advanced Practice and oversees the clinical integration of informatics and other clinical initiatives for the oncology service line. Dr. Kurtin has 37 years of oncology experience, 29 of those in advanced practice.
Dr. Kurtin is a founding Board Member and current President of the Advanced Practitioner Society for Hematology and Oncology (APSHO) and maintains membership in ASH, ASCO, ACCC, AANP, ONS, and the Nightingale Honors Society. She is on the Executive Committee and Board of Directors for the International MDS Foundation and is a member of the Commission on Cancer. She was awarded the 2019 ONS Excellence in Medical Oncology Award and the Arizona March of Dimes Advanced practitioner of the Year (2021) and Nurse of the Year Award for Mentoring (2010). Dr. Kurtin has presented numerous regional, national, and international lectures on oncology related topics, including, the pathobiology of cancer, differential diagnosis and risk adapted treatment, symptom management and clinical research. She is an Associate Editor for The Journal of the Advanced Practitioner in Oncology and is an editorial board member for JCO Clinical Cancer Informatics, The Oncology Nurse, and the ASCO People Living with Cancer website. Dr. Kurtin has published patient and caregiver handbooks, book chapters, and numerous articles in peer-reviewed journals including the New England Journal of Medicine, Cancer Nursing, Clinical Leukemia, Blood, Leukemia Research, The Journal of the Advanced Practitioner in Oncology, and The Clinical Journal of Oncology Nursing.
In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Horizon CME (HCME) ensures that continuing education activities are balanced, independent, objective, and scientifically rigorous.
All persons in a position to influence the content of an accredited continuing education activity provided by Horizon CME are required to disclose to HCME any relevant financial relationships with ineligible companies within the past 24 months. All reported relevant financial relationships have been mitigated by Horizon CME.
Sandra Kurtin, PhD, ANP-C, AOCN has Advisory Boards and Consulting Fees with Incyte, AstraZeneca, Pharmacyclics, BMS, Epizym, during the past 24 months.*
- 1.00 AMA PRA Category 1 Credit™Horizon CME designates this Enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 ANCCThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Nurses Credentialing Center’s Commission on Accreditation through the joint providership of the Nurse Practitioner Healthcare Foundation and Horizon CME. The Nurse Practitioner Healthcare Foundation is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. NPHF is awarding the contact hours and is responsible for adherence to the ANCC criteria. This course is approved by the Nurse Practitioner Healthcare Foundation, California Board of Registered Nursing, CEP# 16441. Upon completion, NPs and RNs will be awarded up to 1.00 credit.
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Complete the post-test and score a minimum of 70%
- Submit the evaluation form
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Access to the internet is required.
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above